coAAV-CSF-01

N/A

Report date: 2025/05/13 15:25:02

Base Information

Drug NamecoAAV-CSF-01
Drug Alias NamecoAAV-CSF-01S01coAAV2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCNS modulators
TargetsUpdating
Therapy Area/IndicationsNeurodegenerative DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoave Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesCoave Therapeutics SA
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A